MedTrace Logo

Brief Trainings to Buffer Against Acute Stress Effects

NCT02214264 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 172

Last updated 2019-05-23

No results posted yet for this study

Summary

The purpose of this study is to evaluate and compare the effectiveness of several brief trainings based on contemplative practices and positive psychology to buffer against the negative effects that acute stress has on behavior and cognitive abilities. The investigators hypothesize that training will buffer against negative effects of acute stress.

Conditions

  • Stress

Interventions

BEHAVIORAL

Loving-Kindness meditation training

Participants undergo training for approximately 12 minutes. Training involves guided reflections and intentions related to feeling loving-kindness towards the self and others.

BEHAVIORAL

Breath Awareness meditation training

Participants undergo training for approximately 12 minutes. Training involves guided awareness focused on sensations of breathing.

BEHAVIORAL

Gratitude

Participants undergo training for approximately 12 minutes. Training involves reflections of gratitude for people, events, and things in one's life.

BEHAVIORAL

Control

Participants will write and then think about the physical space in which they live (i.e., their home) for approximately 12 minutes.

Sponsors & Collaborators

  • University of Wisconsin, Madison

    lead OTHER

Principal Investigators

  • Stacey Schaefer · University of Wisconsin, Madison

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2015-05-31
Completion
2015-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02214264 on ClinicalTrials.gov